Clinical Trial Update: A Clinical Study on Causticum 200 Centesimal Potency in Primary Enuresis [Phase 3]

View source ↗

Summary

Phase 3 clinical study evaluating Causticum 200C for primary nocturnal enuresis (bed-wetting); the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturnal Enuresis

Drugs mentioned

• Causticum 200C (Causticum)

Snippet

Sponsor: Fr Muller Homoeopathic Medical College | Conditions: Bed Wetting, Primary Enuresis | Phase 3 | Status: UNKNOWN